| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000040435 |
| Receipt No. | R000043735 |
| Scientific Title | A comparison between bispectral index (BIS) and patient state index (PSI) in elderly patients under general anesthesia with propofol |
| Date of disclosure of the study information | 2020/05/21 |
| Last modified on | 2021/05/07 (Ver. 2) |
| Basic information | ||
| Public title | A comparison between bispectral index (BIS) and patient state index (PSI) in elderly patients under general anesthesia with propofol | |
| Acronym | A comparison between bispectral index (BIS) and patient state index (PSI) in elderly patients under general anesthesia with propofol | |
| Scientific Title | A comparison between bispectral index (BIS) and patient state index (PSI) in elderly patients under general anesthesia with propofol | |
| Scientific Title:Acronym | A comparison between bispectral index (BIS) and patient state index (PSI) in elderly patients under general anesthesia with propofol | |
| Region |
|
|
| Condition | |||||||||||||
| Condition | head, neck and throat disease, extremities and peripheral vessel disease, disease of the chest wall, abdominal wall and perineum | ||||||||||||
| Classification by specialty |
|
||||||||||||
| Classification by malignancy | Others | ||||||||||||
| Genomic information | NO | ||||||||||||
| Objectives | |
| Narrative objectives1 | The objective of this study is to compare the efficacy of bispectral index (BIS) and patient state index (PSI) in eldery patients scheduled general anesthesia with propofol. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | the duration from discontinuation of the propofol to extubation |
| Key secondary outcomes | the incidence of awareness with recall during anesthesia, the incidence of postoperative delirium within 7 days after the operation, and the incidence of myocardial infarction and stroke within 30 days after the operation |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | The duration of intevention is from obtaining patients' concent and confirming
the eligibility criteria to 30th day after the operation. |
|
| Interventions/Control_2 | The number of intervention is one. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients are included if they meet the following eligibility criteria: (1)65 yr old or older; (2)the expected operative duration is from 2 to 8 hours; (3)scheduled head, neck and throat surgery, extremities and peripheral vessel surgery, the chest wall, abdominal wall and perineum surgery. | |||
| Key exclusion criteria | Patients are excluded if they meet the following exclusion criteria: (1)cerebral parenchyma disease, cerebrovascular
disease, myelopathy, peripheral neuropathy, myopathy, mental disorder, dementia; (2)left ventricular ejection fraction is less than 50%, heart valve disease classified moderate or severe; (3)% vital capacity is less than 80%, and/or forced expiratory volume % in 1 second is less than 70%; (4)liver disease classified Child-Pugh B or C; (5)kidney disease with estimated glomerular filtration rate less than 60 mL/min/1.73m2; (6)diabetes mellitus with HbA1c greater than or equal to 8%; (7)body mass index (BMI) is less than 18.5 or greater than or equal to 25.0; (8)scheduled epidural anesthesia and/or peripheral nerve block; (9)emergency operation. |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Yamaguchi University Faculty of Medicine and Health Sciences, Yamaguchi University Hospital | ||||||
| Division name | the department of Anesthesiology-Resuscitology | ||||||
| Zip code | 755-8505 | ||||||
| Address | 1-1-1, Minamikogushi, Ube City, Yamaguchi Prefecture, Japan | ||||||
| TEL | 0836-22-2111 | ||||||
| kaneshu@yamaguchi-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Yamaguchi University Faculty of Medicine and Health Sciences, Yamaguchi University Hospital | ||||||
| Division name | the department of Anesthesiology-Resuscitology | ||||||
| Zip code | 755-8505 | ||||||
| Address | 1-1-1, Ube City, Yamaguchi Prefecture, Japan | ||||||
| TEL | 0836-22-2291 | ||||||
| Homepage URL | |||||||
| kaneshu@yamaguchi-u.ac.jp | |||||||
| Sponsor | |
| Institute | Yamaguchi University Faculty of Medicine and Health Sciences, Yamaguchi University Hospital, the department of Anesthesiology-Resuscitology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | contribution |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Center For Clinical Research. Yamaguchi University Hospital |
| Address | 1-1-1, Minamikogushi, Ube City, Yamaguchi Prefecture, Japan |
| Tel | 0836-22-2428 |
| clin_res@yamaguchi-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 山口大学医学部附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043735 |